openPR Logo
Press release

H1N1 (Swine Flu) Vaccination Market to Reach at a Highest CAGR of 17% With Top Key Players Baxter International Inc., GSK, CSL, MedImmune, Merck, Novartis, Sanofi Pasteur, NOVAVAX INC, Zydus Group, Crucell, and More

08-03-2018 12:06 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

H1N1 (Swine Flu) Vaccination Market to Reach at a Highest CAGR

Global H1N1 (Swine Flu) Vaccination Industry 2018 Market Research Report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers. Second on basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Credit Insurance, revenue and market share, for key manufacturers.

The Global H1N1 (Swine Flu) Vaccination Market is expected to reach USD 8.26 billion by 2025, from USD 0.6 billion in 2017 growing at a CAGR of 17% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

For In depth Information Get Free Sample Copy of this Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-h1n1-swine-flu-vaccination-market

Global H1N1 (Swine Flu) Vaccination Market, By Treatment type (influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella), End User (Hospital, Clinics), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025

Complete report on Global H1N1 (Swine Flu) Vaccination Market Research Report 2018-2025 spread across 350 Pages, profiling Top companies and supports with tables and figures

Market Definition: Global H1N1 (Swine Flu) Vaccination Market

Swine flu is an infection caused by H1N1 virus, also known as swine flu virus. In 2009, H1N1 had spread rapidlyaround the world, so the World Health Organization called it a pandemic. The H1N1 virus mainly affects the respiratory system including nose, lungs and throat of the infected person. H1N1 virus can be classified on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Vaccine, suspension of weakened, killed, or fragmented microorganisms or toxins or of antibodies or lymphocytes is administered primarily to prevent disease. The market for H1N1 flu is growing tremendously due to increased awareness. For instance, according to centers for disease control and prevention, in 2009 during pandemic approximately 60.8 million cases, 274,304 hospitalizations and 12,469 deaths occurred due to H1N1 swine flu. There have been tremendous technological advancements in the field of vaccination in the last decade. For instance, in 2006, U.S. Department of Health and Human Services awarded $1 billion in funding to a number of vaccine makers, including GlaxoSmithKline, Novartis, and MedImmune, to develop alternative production methods.

Key Questions Answered in Global H1N1 (Swine Flu) Vaccination Market Report:-

Our Report offers:-

• What will the market growth rate, Overview and Analysis by Type of Global H1N1 (Swine Flu) Vaccination Market in 2025?

• What are the key factors driving, Analysis by Applications and Countries Global H1N1 (Swine Flu) Vaccination Market?

• What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Global H1N1 (Swine Flu) Vaccination Market?

• Who are Opportunities, Risk and Driving Force of Global H1N1 (Swine Flu) Vaccination Market?

• Who are the opportunities and threats faced by the vendors in Global H1N1 (Swine Flu) Vaccination Market? Business Overview by Type, Applications, Gross Margin and Market Share

• What are the Global H1N1 (Swine Flu) Vaccination Market opportunities, market risk and market overview of the Market?

Request for Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-h1n1-swine-flu-vaccination-market

Top Key Players:

• Baxter Healthcare
• GlaxoSmithKline
• CSL
• Medimmune (Astra Zeneca)
• Merck & Co. Inc
• Novartis
• Sanofi Pasteur
• Sinovac
• Hualan Biological Engineering Co.
• Novovax
• Commonwealth Serum Laboratories
• Zydus Cadila
• Panacea Biotec
• Shanghai Institute Of Biological Products
• Sinovac Biotech LTD Butantan Institute
• Cantacuzino Institute Of Sera And Vaccine
• Changchun Institute Of Biological Product
• Crucell N.V.
• Denka Seiken Co Ltd.
• Green Cross Corp.
• Glaxosmithkline Plc
• amongst others.

Key Reasons to Purchase:

• To gain insightful analyses of the market and have comprehensive understanding of the Global H1N1 (Swine Flu) Vaccination Market and its commercial landscape.

• Assess the H1N1 (Swine Flu) Vaccination production processes, major issues, and solutions to mitigate the development risk.

• To understand the most affecting driving and restraining forces in the H1N1 (Swine Flu) Vaccination Market and its impact in the Global market.

• Learn about the market strategies that are being adopted by leading respective organizations.

• To understand the future outlook and prospects for Global H1N1 (Swine Flu) Vaccination Market.

Avail 10% Instant Discount on Purchase of This Report Mail @ sopan.gedam@databridgemarketresearch.com

Major Market Drivers and Restraints:

• Cost of H1N1 Vaccine
• Vaccine awareness
• Side-effects of vaccine
• Availability of substitute treatment
• Limited consumer segments
• Ease in administration

Key Insights in the report:

• Historical and current market size and projection up to 2025
• Market trends impacting the growth of the global H1N1 (Swine Flu) Vaccination market
• Analyze and forecast the H1N1 (Swine Flu) Vaccination market on the basis of services, end-user, and services
• Trends of key regional and country-level markets for processes, derivative and application
• Company profiling of key players which includes business operations, product and services, geographic presence, recent developments and key financial analysis

Key Developments in the Market:

• January 2010: The World Health Organization defended itself against allegations it overhyped the dangers of H1N1 under pressure from vaccine manufacturers at a hearing of the Council of Europe’s health committee.

• October, 2009: Baxter International (U.S) got approval from European Commission (EC) for marketing authorization of CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvant pandemic influenza vaccine to receive marketing authorization in the European Union.

Inquire Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-h1n1-swine-flu-vaccination-market

Customize report of "Global H1N1 (Swine Flu) Vaccination Market" as per customers requirement also available.

Market Segmentations:

Global H1N1 (Swine Flu) Vaccination Market is segmented on the basis of
• Treatment Type
• End User
• Geography

Market Segmentations in Details:

By Treatment Type
• Influenza
• Meningococcal
• Cervical Cancer
• Pneumococcal
• Hepatitis
• Measles
• Mumps
• Rubella

By End User
• Hospital
• Clinics

By Geography

North America
• U.S.
• Canada,
• Mexico

Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Turkey
• Belgium
• Netherlands
• Switzerland
• Rest of Europe

Asia-Pacific
• Japan
• China
• South Korea
• India
• Australia
• Singapore
• Thailand
• Malaysia
• Indonesia
• Philippines
• Rest of Asia Pacific

South America
• Brazil
• Rest of South America

Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Rest of MEA

Competitive Analysis: Global H1N1 (Swine Flu) Vaccination Market

The global H1N1 (swine flu) vaccination market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes global H1N1 (swine flu) vaccination market for global, Europe, North America, Asia Pacific and South America.

Speak to Author of the report @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-h1n1-swine-flu-vaccination-market

Other Report

Global Innovation Management Market – Industry Trends and Forecast to 2024

Global Innovation Management Market, By Geography; Type (Software, Services); Organization Size (Large Enterprises, Small & Medium-sized Enterprises (SMEs)); Deployment Model (On-premises, Cloud); Application (Product Research & Development Platforms, Marketing, Design, Idea Platforms, Collective Intelligence & Prediction Platforms, Human Resource & Freelancers Platforms); Vertical (Banking, Financial Services, Insurance, IT, Media & Communication Technology, Aerospace & Defense, Public Sector & Education, Healthcare & Pharmaceuticals, Retail & Consumer Goods, Automotive & Manufacturing, Transportation & Logistics) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-innovation-management-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release H1N1 (Swine Flu) Vaccination Market to Reach at a Highest CAGR of 17% With Top Key Players Baxter International Inc., GSK, CSL, MedImmune, Merck, Novartis, Sanofi Pasteur, NOVAVAX INC, Zydus Group, Crucell, and More here

News-ID: 1161167 • Views:

More Releases from Data Bridge Market Research

Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, …
"Preparative and Process Chromatography Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis.
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Deman …
"Global Sodium Lactate Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. The document also explains key elements such as revenue, business distribution, market share, shipment, gross profit, and more. All these elements help the readers to understand more information about industry competitors. Being the most suitable example of the above attributes, the
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Tren …
Data Bridge Market research has recently released expansive research titled Global Cold Chain Monitoring Components Market guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
The rise in demand for water treatment in industrial applications across the globe acts as one of the major factors driving the growth of sodium hypophosphite market. The rise in usage of sodium hypophosphite in the electroplating application as reducing agents, and increase in electroplating of metal surface assist in enhancing properties such as abrasion resistance, hardness, corrosion resistance, and strength among others accelerate the market growth. The increase in

All 5 Releases


More Releases for H1N1

H1N1 Vaccines Market Opportunity Analysis, 2018 – 2026
H1N1 influenza virus causes viral disease, commonly known as swine flu, which mostly affects the respiratory system. Swine flu is characterized by infection from H1N1 strain. Symptoms of H1N1 flu are fever, cough, sore throat, runny or stuffy nose, watery and red eyes, body aches, headache, fatigue, and diarrhea. H1N1 spreads through contact with contaminated air or geographical locations infected with virus. H1N1 infection may worsen other chronic respiratory conditions
H1N1 Vaccines Market Expansion to be Persistent by 2021
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Vaccines can be categorized into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate. Cholera, influenza, hepatitis A, polio, and rabies vaccines are inactivated vaccines. The global vaccines market is categorized on the
H1N1 Vaccination Market - Global Industry Analysis 2023
H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred as swine flu. The H1N1 virus mainly affects the respiratory system including nose, lungs and throat of the infected person. In addition to human, H1N1 virus affects various species such as birds, swine, horses etc. The H1N1 influenza virus caused a worldwide pandemic in the recent
H1N1 Vaccination Market Opportunities and Forecast by 2023
H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred as swine flu. The H1N1 virus mainly affects the respiratory system including nose, lungs and throat of the infected person. In addition to human, H1N1 virus affects various species such as birds, swine, horses etc. The H1N1 influenza virus caused a worldwide pandemic in the recent
H1N1 Vaccines Market Rugged Expansion Foreseen by 2021
The H1N1 Vaccines Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one
Europe H1N1 Vaccines Market 2017
Latest market study on " Europe H1N1 Vaccines Market Report: 2017 " available with Single User Europe USD 3900 at OrbisResearch.com The H1N1 Vaccines Market report covers the present scenario and the growth prospects of the Europe H1N1 Vaccines market for 2017-2022 The report covers the market landscape and its growth prospects over the coming years. To calculate the market size , market share, market growth, market analysis , market